NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 211 filers reported holding NEVRO CORP in Q2 2020. The put-call ratio across all filers is 0.77 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $191,623 | +39.0% | 9,970 | +83.8% | 0.00% | 0.0% |
| Q2 2023 | $137,853 | -29.7% | 5,423 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $196,041 | -8.7% | 5,423 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $214,751 | +1.8% | 5,423 | +19.9% | 0.00% | 0.0% |
| Q3 2022 | $211,000 | +6.6% | 4,523 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $198,000 | -40.0% | 4,523 | -0.8% | 0.00% | -50.0% |
| Q1 2022 | $330,000 | -10.8% | 4,561 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $370,000 | -5.1% | 4,561 | +35.9% | 0.00% | 0.0% |
| Q3 2021 | $390,000 | -29.9% | 3,355 | 0.0% | 0.00% | -33.3% |
| Q2 2021 | $556,000 | +18.8% | 3,355 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $468,000 | -29.1% | 3,355 | -12.0% | 0.00% | -25.0% |
| Q4 2020 | $660,000 | +24.3% | 3,811 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $531,000 | +37.6% | 3,811 | +17.9% | 0.00% | +33.3% |
| Q2 2020 | $386,000 | +65.0% | 3,232 | +38.2% | 0.00% | +50.0% |
| Q1 2020 | $234,000 | -9.3% | 2,338 | +6.5% | 0.00% | 0.0% |
| Q4 2019 | $258,000 | +68.6% | 2,195 | +23.2% | 0.00% | +100.0% |
| Q3 2019 | $153,000 | +31.9% | 1,782 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $116,000 | +4.5% | 1,782 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $111,000 | +60.9% | 1,782 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $69,000 | -32.4% | 1,782 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $102,000 | -28.2% | 1,782 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $142,000 | +23.5% | 1,782 | +34.3% | 0.00% | 0.0% |
| Q1 2018 | $115,000 | +25.0% | 1,327 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $92,000 | -4.2% | 1,327 | +25.3% | 0.00% | 0.0% |
| Q3 2017 | $96,000 | +21.5% | 1,059 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $79,000 | -11.2% | 1,059 | +11.9% | 0.00% | 0.0% |
| Q1 2017 | $89,000 | +29.0% | 946 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $69,000 | -46.9% | 946 | -23.8% | 0.00% | 0.0% |
| Q3 2016 | $130,000 | +52.9% | 1,241 | +7.1% | 0.00% | 0.0% |
| Q2 2016 | $85,000 | +286.4% | 1,159 | +199.5% | 0.00% | – |
| Q1 2016 | $22,000 | -15.4% | 387 | 0.0% | 0.00% | – |
| Q4 2015 | $26,000 | +225.0% | 387 | +117.4% | 0.00% | – |
| Q3 2015 | $8,000 | – | 178 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 562,833 | $40,710,000 | 4.84% |
| Altium Capital Management LP | 77,000 | $5,569,000 | 1.86% |
| PFM Health Sciences, LP | 649,513 | $46,979,000 | 1.76% |
| Rock Springs Capital Management LP | 721,500 | $52,186,000 | 1.31% |
| Integral Health Asset Management, LLC | 50,000 | $3,617,000 | 0.94% |
| Redmile Group, LLC | 411,017 | $29,729,000 | 0.93% |
| K2 PRINCIPAL FUND, L.P. | 114,800 | $8,303,000 | 0.72% |
| Connacht Asset Management LP | 18,762 | $1,357,000 | 0.70% |
| Perceptive Advisors | 477,037 | $34,504,000 | 0.69% |
| ArrowMark Colorado Holdings LLC | 855,439 | $61,874,000 | 0.54% |